Tosoh AIA-360 (97)
Specialty: Endocrinology
Welcome to the PulseAid listing for the Tosoh AIA-360 medical device. This device is used in the Endocrinology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the Endocrinology healthcare specialty at the bottom of the page.
Analytes Measured/Detected and Complexity:
ANALYTE | COMPLEXITY |
Adrenocorticotropic hormone (ACTH) (K111335 | K111335) | MODERATE Effective Date: 2012-01-23 |
C-peptide (X040006 | X040006) | MODERATE Effective Date: 2004-04-29 |
Cancer antigen 125 (CA 125) (K971103 | K971103) | MODERATE Effective Date: 2004-04-05 |
Carcinoembryonic antigen (CEA) (K971103 | K971103) | MODERATE Effective Date: 2004-04-05 |
Cortisol (K971103 | K971103) | MODERATE Effective Date: 2004-04-05 |
Creatine kinase MB fraction (CKMB) (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
Cystatin C (K093960 | K093960) | MODERATE Effective Date: 2011-05-04 |
Dehydroepiandrosterone sulfate (DHEA-SO4) (X110125 | X110125) | MODERATE Effective Date: 2011-11-21 |
Estradiol (K971103 | K971103) | MODERATE Effective Date: 2004-04-05 |
Ferritin (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
Follicle stimulating hormone (FSH) (K971103 | K971103) | MODERATE Effective Date: 2004-04-05 |
Glycosylated Hemoglobin (Hgb A1c) (K100304 | K100304) | MODERATE Effective Date: 2011-01-05 |
hCG, beta, serum, quantitative (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
hCG, Intact, serum, quantitative (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
Homocysteine (K121533 | K121533) | MODERATE Effective Date: 2012-07-17 |
Human growth hormone (GH) (X040007 | X040007) | MODERATE Effective Date: 2004-04-29 |
Insulin (K971103 | K971103) | MODERATE Effective Date: 2004-04-05 |
Luteinizing hormone (LH) (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
Myoglobin (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
Parathyroid hormone – intact (K063605 | K063605) | MODERATE Effective Date: 2009-02-25 |
Progesterone (K971103 | K971103) | MODERATE Effective Date: 2005-02-17 |
Prolactin (K971103 | K971103) | MODERATE Effective Date: 2004-04-05 |
Testosterone (K023091 | K023091) | MODERATE Effective Date: 2004-06-28 |
Thyroid stimulating hormone (TSH) (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
Thyroxine (T4) (K971103 | K971103) | MODERATE Effective Date: 2005-02-17 |
Thyroxine uptake (T4U) (TU) (K971103 | K971103) | MODERATE Effective Date: 2005-02-17 |
Thyroxine, free (FT4) (K971103 | K971103) | MODERATE Effective Date: 2005-02-17 |
Triiodothyronine (T3) (K971103 | K971103) | MODERATE Effective Date: 2005-02-17 |
Triiodothyronine, free (FT3) (K971103 | K971103) | MODERATE Effective Date: 2005-02-17 |
Troponin-I (cardiac) (K971103 | K971103) | MODERATE Effective Date: 2004-03-02 |
Other Tosoh AIA-360 Medical Devices:
Medical Device | Complexity |
Tosoh AIA-360 (170) Prostatic specific antigen (PSA) | | View Complexity |
Tosoh AIA-360 (4477) Prostatic acid phosphatase (PAP) | | View Complexity |
Tosoh AIA-360 (4478) Beta-2 microglobulin | | View Complexity |
Tosoh AIA-360 (4480) Immunoglobulins IgE | | View Complexity |
Tosoh AIA-360 (4499) Cancer antigen 27.29 (CA 27.29) | | View Complexity |
Tosoh AIA-360 (4502) CA 19-9 | | View Complexity |
Tosoh AIA-360 (4504) Alpha-fetoprotein – tumor marker | | View Complexity |